Start a New Search
SHOWING 313 RESULTS
AAU, APLU Question NIH F&A Reimbursement Policy for Genomic Arrays.
Agency Budgets | National Institutes of Health | Costs of Research (F&A Costs) | Research Administration & Regulation | LettersThe federal government sponsors university research to help our country prosper.
Research Administration & Regulation | Costs of Research (F&A Costs) | Issue BriefSally Rockey, explains indirect costs and how they support research.
Research Administration & Regulation | Costs of Research (F&A Costs) | TestimonyReport identifies specific actions Congress, the White House, federal agencies, and research institutions should take to reduce regulatory burden.
Research Administration & Regulation | Costs of Research (F&A Costs) | ReportsThe Coalition for National Science Funding, which includes AAU, sent a letter thanking the Appropriations committees in both the U.S. House of Representatives and Senate for their continued support in NSF funding for the Fiscal Year 2022.
FY22 | Costs of Research (F&A Costs) | National Science Foundation | LettersAAU submitted a response to the National Institutes of Health’s request for public comments to enhance public access to the results of NIH-supported research.
National Institutes of Health | Research Administration & Regulation | Costs of Research (F&A Costs) | MemoF&A Costs of Research one-pager
Costs of Research (F&A Costs) | Research Administration & Regulation | Issue BriefStatement from AAU President Barbara R. Snyder on NIH's announcement that it will cut reimbursement of facilities and administrative (F&A) research costs.
Costs of Research (F&A Costs) | Research Administration & Regulation | Press ReleasesAAU, ACE, and APLU have jointly filed suit in U.S. District Court in Massachusetts, along with a number of impacted research university co-plaintiffs, seeking to halt the NIH's proposed cut to life-saving medical research.
National Institutes of Health | Research Administration & Regulation | Costs of Research (F&A Costs) | Press ReleasesThis is a legal filing contesting the unlawful and damaging decree by the administration to cap F&A reimbursement rates to a 15% for all NIH research.
Costs of Research (F&A Costs) | Research Administration & Regulation | National Institutes of Health | Legal Filing